Coeptis Therapeutics Holdings, Inc. Banner Image

Coeptis Therapeutics Holdings, Inc.

  • Ticker COEP
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Coeptis Therapeutics Holdings, Inc. Logo Image
  • 201-500 Employees
  • Based in Wexford, Pennsylvania
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., (collectively "Coeptis"), is a biopharmaceutical company developing innovative cell therapy platforms for cancer that have the potential to disrupt conventional treatment paradigms and improve patient outcomes. Coeptis' product portfolio and rightsMore are highlighted by a universal, multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEARâ„¢ cell therapy and companion diagnostic platforms, which Coeptis is developing with VyGen-Bio and leading medical researchers at the Karolinska Institutet. Coeptis' business model is designed around maximizing the value of its current product portfolio and rights through in-license agreements, out-license agreements and co-development relationships, as well as entering into strategic partnerships to expand its product rights and offerings, specifically those targeting cancer.
3.0 / 5.0 (3)

Coeptis Therapeutics Holdings, Inc. reports have an aggregate usefulness score of 3.0 based on 3 reviews.

Coeptis Therapeutics Holdings, Inc.

Most Recent Annual Report

Coeptis Therapeutics Holdings, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Coeptis Therapeutics Holdings, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!